A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany

NCT06104644 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
550
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb